Press Releases

Press Releases

February 22, 2021
SAN DIEGO , Feb. 22, 2021 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), a leading autoimmune organization, today announced its participation in the Cowen 41st Annual Health Care Conference which takes place March 1-4, 2021 . Ron Rocca , Exagen’s President and Chief Executive Officer, and Kamal
January 10, 2021
Record Testing Revenue, Adopters and AVISE CTD ® Volumes SAN DIEGO , Jan. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported preliminary, unaudited financial results for
January 5, 2021
SAN DIEGO , Jan. 05, 2021 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the 2021 ICR Conference , which takes place January